Interstitial Cystitis Association of America Inc (EIN 133292137) - Form 990 Financial Analysis & Trantor Score

🔒

Tuckman-Chang Vulnerability Assessment

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1984

Legal Domicile

Principal Officer

Claudia King

Phone

7034422070

Tax Period

2023-10-01 to 2024-09-30

Interstitial Cystitis Association of America Inc, founded in 1984, is a small nonprofit that reported $771K in total revenue in fiscal year 2017. Revenue surged 41% from the prior year, signaling strong growth momentum. Expenses of $694K left a modest 10% surplus.

Mission

The ICA advocates for research dedicated to discovery of a cure and better treatments, raises awareness, and serves as a central hub for the healthcare providers, researchers and millions of patients who suffer with constant urinary urgency and frequency and extreme bladder pain called IC/BPS, or interstitial cystitis/bladder pain syndrome.

🔒

Trantor Score

Financial Health & Payment Capacity Assessment (FICO Scale: 300–850)

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $390,726

Program Service Revenue $92,884

Investment Income $891

Other Revenue $2,463

TOTAL REVENUE $486,964

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $90,473

Program Expenses $507,971

Other Expenses $633,847

TOTAL EXPENSES $633,847

Year-over-Year Comparison

	2023	2022	Change
Revenue	$486,964	$647,913	-0.2%
Expenses	$633,847	$648,895	0.0%
Net Income	$-146,883	$-982	+148.6%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✓ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✓ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Laura Santurri	Chair	3.00	Officer Director	$0	$0	$0
Claudia King	Vice Chair	3.00	Officer Director	$0	$0	$0
Michael Greenwell	Immediat Past Chair	1.00	Officer Director	$0	$0	$0
Amber Carter	Director	1.50	Director	$0	$0	$0
Theda Khrestin	Director	1.50	Director	$0	$0	$0
Shelley Kardon	Director	1.50	Director	$0	$0	$0
Sarah Cojocaru	Director	1.50	Director	$0	$0	$0
Ilka Ross	Director	1.50	Director	$0	$0	$0
David Klumpp	Director	1.50	Director	$0	$0	$0
Chris Meenan	Director	1.50	Director	$0	$0	$0
Eric Zarnikow	Director	1.50	Director	$0	$0	$0
Natasha Boswell	Director	1.50	Director	$0	$0	$0
Tacha Kasper	Director	1.50	Director	$0	$0	$0
Rick Lufkin	Director	1.50	Director	$0	$0	$0
Janelle Faba	Director	1.50	Director	$0	$0	$0
Lee Lowery	Executive Director	10.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$486,964	$633,847	$165,553	$-146,883
2023	$647,913	$648,895	$315,917	$-982
2022	$604,676	$629,962	$304,762	$-25,286
2021	$745,097	$709,663	$352,600	$35,434
2020	$780,198	$696,585	$312,578	$83,613
2019	$632,190	$742,537	$225,225	$-110,347
2018	$770,504	$694,190	$327,851	$76,314

Interstitial Cystitis Association of America Inc